Genesee Capital Advisors LLC Acquires New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Genesee Capital Advisors LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 2,085 shares of the healthcare conglomerate’s stock, valued at approximately $815,000.

Other hedge funds also recently bought and sold shares of the company. Atom Investors LP bought a new position in UnitedHealth Group during the 2nd quarter valued at approximately $1,723,000. GWM Advisors LLC increased its holdings in shares of UnitedHealth Group by 8.3% in the 2nd quarter. GWM Advisors LLC now owns 31,240 shares of the healthcare conglomerate’s stock worth $12,510,000 after purchasing an additional 2,397 shares in the last quarter. Seven Springs Wealth Group LLC increased its holdings in shares of UnitedHealth Group by 58.6% in the 2nd quarter. Seven Springs Wealth Group LLC now owns 2,544 shares of the healthcare conglomerate’s stock worth $1,019,000 after purchasing an additional 940 shares in the last quarter. Parametric Portfolio Associates LLC increased its holdings in shares of UnitedHealth Group by 2.2% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,874,820 shares of the healthcare conglomerate’s stock worth $1,551,633,000 after purchasing an additional 81,995 shares in the last quarter. Finally, Welch & Forbes LLC increased its holdings in shares of UnitedHealth Group by 46.2% in the 2nd quarter. Welch & Forbes LLC now owns 4,572 shares of the healthcare conglomerate’s stock worth $1,831,000 after purchasing an additional 1,445 shares in the last quarter. 86.20% of the stock is owned by institutional investors.

Shares of UnitedHealth Group stock opened at $450.16 on Thursday. The stock’s 50-day simple moving average is $430.47 and its 200-day simple moving average is $418.01. UnitedHealth Group Incorporated has a 52 week low of $320.35 and a 52 week high of $466.00. The company has a market capitalization of $423.98 billion, a price-to-earnings ratio of 27.93, a PEG ratio of 1.75 and a beta of 0.85. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, October 14th. The healthcare conglomerate reported $4.52 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $4.41 by $0.11. UnitedHealth Group had a return on equity of 23.08% and a net margin of 5.52%. The business had revenue of $72.34 billion for the quarter, compared to the consensus estimate of $71.24 billion. During the same period in the previous year, the business earned $3.51 earnings per share. The business’s revenue was up 11.1% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 18.84 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Stockholders of record on Monday, December 6th will be issued a $1.45 dividend. The ex-dividend date of this dividend is Friday, December 3rd. This represents a $5.80 annualized dividend and a dividend yield of 1.29%. UnitedHealth Group’s dividend payout ratio (DPR) is 35.98%.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction that occurred on Monday, October 25th. The stock was sold at an average price of $448.72, for a total transaction of $33,654,000.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction that occurred on Tuesday, September 14th. The stock was sold at an average price of $416.75, for a total value of $1,041,875.00. Following the sale, the director now directly owns 154,403 shares in the company, valued at $64,347,450.25. The disclosure for this sale can be found here. Insiders sold 82,500 shares of company stock worth $36,855,125 over the last ninety days. Insiders own 0.55% of the company’s stock.

A number of research firms have commented on UNH. Wells Fargo & Company lifted their target price on UnitedHealth Group from $478.00 to $520.00 and gave the stock an “overweight” rating in a report on Monday, October 25th. SVB Leerink initiated coverage on UnitedHealth Group in a report on Monday, September 27th. They issued an “outperform” rating and a $480.00 price objective for the company. Evercore ISI lifted their price objective on UnitedHealth Group from $360.00 to $480.00 and gave the stock an “outperform” rating in a report on Friday, October 15th. Cowen initiated coverage on UnitedHealth Group in a report on Thursday, September 9th. They issued an “outperform” rating and a $478.00 price objective for the company. Finally, Credit Suisse Group lifted their price objective on UnitedHealth Group from $462.00 to $495.00 and gave the stock an “outperform” rating in a report on Friday, October 15th. One analyst has rated the stock with a hold rating, twenty-one have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $477.35.

UnitedHealth Group Profile

UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.

Recommended Story: What is channel trading?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.